|
" Developing biomarker-based tools for cancer screening, diagnosis, and treatment : "
Margie Patlak and Sharyl Nass, rapporteurs; National Cancer Policy Forum.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
780876
|
| Doc. No
|
:
|
b600884
|
| Main Entry
|
:
|
Margie Patlak and Sharyl Nass, rapporteurs; National Cancer Policy Forum.
|
| Title & Author
|
:
|
Developing biomarker-based tools for cancer screening, diagnosis, and treatment : : the state of the science, evaluation, implementation, and economics : workshop summary\ Margie Patlak and Sharyl Nass, rapporteurs; National Cancer Policy Forum.
|
| Publication Statement
|
:
|
Washington, D.C.: National Academies Press, ©2006.
|
| Page. NO
|
:
|
(x, 102 pages) : illustrations
|
| ISBN
|
:
|
0309658144
|
|
|
:
|
: 1280704926
|
|
|
:
|
: 9780309658140
|
|
|
:
|
: 9781280704925
|
| Contents
|
:
|
Cover --; Reviewers --; Contents --; Introduction --; Overview of Technologies Used to Discover Cancer Biomarkers --; Genomics, Proteomics, and Metabolomics --; Molecular Imaging --; Meeting the Technical Challenges of Biomarker Validation and Qualification --; Coordinating the Development of Biomarkers and Targeted Therapies --; Therapeutics Industry Perspective --; Diagnostics Industry Perspective --; NCI Perspective --; Clinical Investigator Perspective --; Biomarker Development and Regulatory Oversight --; FDA Critical Path Initiative --; Oversight of Diagnostic Tests --; Designing Clinical Studies of Biomarkers --; Assessment and Adoption of Biomarker-Based Technologies --; Federal Programs for Technology Assessment --; Insurance Coverage Decisions and Practice Guidelines --; CMS Coverage of Biomarkers --; Economic Impact of Biomarkers --; Cost-Effectiveness Analysis --; The Value of Information and Research --; Technology Assessment in the Private Sector --; Clinical Development Strategies for Biomarker Utilization Discussion --; Strategies for Implementing Standardized Biorepositories Discussion --; Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion --; Strategies to Develop Biomarkers for Early Detection Discussion --; Mechanisms for Developing an Evidence Base Discussion --; Evaluation of Evidence in Decision Making Discussion --; Incorporating Biomarker Evidence Into Clinical Practice Discussion --; Acronyms --; Glossary --; References --; Appendixes --; Appendix A Workshop Agenda --; Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants --; Last Page.
|
| Subject
|
:
|
Mass Screening -- methods -- Congresses.
|
| Subject
|
:
|
Neoplasms -- prevention and control -- Congresses.
|
| Subject
|
:
|
Tumor markers -- Congresses.
|
| LC Classification
|
:
|
RC270.3.T84M374 2006
|
| Added Entry
|
:
|
Margie Patlak
|
|
|
:
|
National Cancer Policy Forum (U.S.)
|
|
|
:
|
Sharyl J Nass
|
|
|
:
|
United States. Department of Health and Human Services.
|
| |